ABBV
AbbVie Inc. · Healthcare · Drug Manufacturers - General
Last
$229.32
−$0.43 (−0.18%) 4:00 PM ET
After hours
$229.00
−$0.31 (−0.14%) 3:20 AM ET
Prev close $229.74
Open $228.05
Day high $230.70
Day low $226.05
Volume 3,204,630
Avg vol 5,470,542
Mkt cap
$403.83B
P/E ratio
173.72
FY Revenue
$59.64B
EPS
1.32
Gross Margin
69.74%
Sector
Healthcare
AI report sections
ABBV
AbbVie Inc.
AbbVie shows a firmly positive medium-term price trend with the stock trading near the upper portion of its 52-week range and above key moving averages, while short-term returns have cooled modestly. Fundamentally, high gross margins and very strong free cash flow generation contrast with pressure on net income, thin equity, and a sizeable debt load. News and sentiment appear constructive around the company’s dividend profile and product diversification but coexist with policy-related headline risk from drug pricing negotiations.
AI summarized at 7:12 PM ET, 2025-12-25
AI summary scores
INTRADAY: 58 SWING: 72 LONG: 69
Volume vs average
Intraday (cumulative)
−2% (Below avg)
Vol/Avg: 0.98×
RSI
52.08 (Neutral)
Neutral (30–70): momentum balanced.
MACD momentum
Intraday
+0.06 (Strong)
MACD: -0.00 Signal: -0.06
Short-Term
+0.53 (Strong)
MACD: 0.63 Signal: 0.10
Long-Term
+0.52 (Strong)
MACD: -0.11 Signal: -0.63
Intraday trend score 51.74
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal